Ann M. Hanly - 30 Mar 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Technology Officer
Signature
/s/ Vanina de Verneuil, Attorney-in-fact
Issuer symbol
VIR
Transactions as of
30 Mar 2023
Net transactions value
-$59,817
Form type
4
Filing time
31 Mar 2023, 14:40:58 UTC
Previous filing
24 Feb 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale $59,817 -2,627 -2.2% $22.77 114,576 30 Mar 2023 Direct F1
holding VIR Common Stock 12 30 Mar 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
F2 The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.